Patent · US Active

Modified pyrazine derivatives and uses thereof

US9005581B2 · kind B2 · utility

10Cited by
6References
14Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 4, 2014
Grant dateApr 14, 2015
Priority date
Expiry dateMar 4, 2034

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D241/26
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Provided herein are compounds, preparations and formulations comprising pyrazine derivatives having multiple poly(ethylene glycol) containing substituents. Many of the compounds disclosed herein are excretable by the renal system of a subject or patient and are useful for visualizing the renal system of a subject or patient. Upon excitation by electromagnetic radiation, a number of the compounds disclosed herein exhibit luminescence and are externally detectable when present in the body fluid of a patient or subject. Also provided herein are methods for visualizing the renal system of a subject or patient.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.